http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2002304019-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b179d6c182010b93cbcd404118b97994 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-22 |
filingDate | 2002-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b48ad6f38efd2db0139f5ceeb6fe62a |
publicationDate | 2004-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2002304019-A1 |
titleOfInvention | Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof |
priorityDate | 2002-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1084.